Acceleron Pharma (XLRN) PT Raised to $171 at Citi

March 1, 2021 5:52 AM EST
Get Alerts XLRN Hot Sheet
Price: $122.05 --0%

Rating Summary:
    17 Buy, 4 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 7 | New: 42
Trade Now! 
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on Acceleron Pharma (NASDAQ: XLRN) to $171.00 (from $137.00) while maintaining a Buy rating.

You May Also Be Interested In

Related Categories

Analyst PT Change